Loading stock data...

Sanjivani Paranteral Limited.

BSE: SANJIVIN

BSE
219.00 -4.05 (-1.82%)

Prev Close

223.05

Open Price

223.05

Volume

7,975

Today Low / High

213 / 223.8

52 WK Low / High

203.1 / 396.95

Range

208 - 230

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 219, reflecting a change of -4.05 (-1.81574%). The expected target range on the BSE is 208 - 230. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

08 Oct 223.05 -1.82%
07 Oct 225.00 -0.87%
06 Oct 228.80 -2.78%
03 Oct 216.10 5.37%
01 Oct 221.50 -0.72%
30 Sep 230.00 -3.59%
29 Sep 231.80 -1.62%
26 Sep 239.90 -3.38%
25 Sep 242.75 -1.17%
24 Sep 240.05 1.10%
23 Sep 240.00 1.23%
22 Sep 247.00 -1.62%
19 Sep 241.75 -0.93%
18 Sep 230.90 3.70%
17 Sep 237.40 -2.74%
16 Sep 232.00 2.33%
15 Sep 237.30 -0.76%
12 Sep 240.25 -1.23%
11 Sep 248.70 -1.55%
10 Sep 250.00 -1.14%

Sanjivani Paranteral Limited. Graph

Sanjivani Paranteral Limited. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Sanjivani Paranteral Limited. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 219.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 219.00 221.19 199.07 - 243.31
223.38 178.70 - 268.06
225.57 157.90 - 293.24
Bearish Scenario 219.00 216.81 195.13 - 238.49
214.62 171.70 - 257.54
212.43 148.70 - 276.16

Overview of Sanjivani Paranteral Limited.

ISIN

INE860D01013

Industry

Medical - Pharmaceuticals

Vol.Avg

8,883

Market Cap

2,690,261,700

Last Dividend

0.5

Official Website

Visit Website

IPO Date

2002-03-22

DCF Diff

455.16

DCF

-227

Financial Ratios Every Investor Needs

Stock Dividend of SANJIVIN

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-19 September 19, 25 0.5 0.5 2025-09-19 2025-10-26

Stock Rating Details for SANJIVIN

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 70.10 Cr 47.60 Cr 22.50 Cr 0.3210 0.00 Cr 2.28 Cr 9.73 Cr 8.09 Cr 6.91 11.57 Cr 0.1155
2024-03-31 53.69 Cr 32.80 Cr 20.89 Cr 0.3891 0.06 Cr 3.61 Cr 7.48 Cr 6.17 Cr 5.28 8.63 Cr 0.1148
2023-03-31 35.24 Cr 21.87 Cr 13.37 Cr 0.3794 0.00 Cr 0.60 Cr -1.95 Cr 4.51 Cr 4.51 6.19 Cr 0.1280
2022-03-31 30.38 Cr 15.24 Cr 15.14 Cr 0.4983 0.00 Cr 0.72 Cr 4.48 Cr 4.85 Cr 4.85 5.97 Cr 0.1595
2021-03-31 24.71 Cr 16.64 Cr 8.07 Cr 0.3267 0.00 Cr 0.35 Cr 0.91 Cr 1.42 Cr 1.67 2.40 Cr 0.0574

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 1.49 Cr 78.20 Cr 38.33 Cr 37.9960 Cr 8.14 Cr 5.73 Cr 10.51 Cr 39.67 Cr 0.00 Cr 0.00 Cr 1.79 Cr 31.7922 Cr
2024-03-31 0.54 Cr 43.41 Cr 15.51 Cr 27.8988 Cr 0.97 Cr 0.43 Cr 13.48 Cr 9.94 Cr 5.02 Cr 0.00 Cr -8.74 Cr 13.7803 Cr
2023-03-31 0.30 Cr 21.01 Cr 24.08 Cr -3.0711 Cr 2.49 Cr 2.19 Cr 5.35 Cr 7.57 Cr 1.44 Cr 0.36 Cr 0.43 Cr 22.6534 Cr
2022-03-31 0.34 Cr 18.30 Cr 25.88 Cr -7.5827 Cr 5.99 Cr 5.65 Cr 1.75 Cr 7.42 Cr 1.47 Cr 0.32 Cr 0.34 Cr 21.8932 Cr
2021-03-31 0.17 Cr 19.28 Cr 64.17 Cr -44.8938 Cr 46.06 Cr 45.88 Cr 0.91 Cr 7.62 Cr 2.29 Cr 0.00 Cr 0.86 Cr 57.6253 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 12.2239 Cr -20.4521 Cr 9.1727 Cr -18.1246 Cr 0.9446 Cr 1.4853 Cr -30.3485 Cr 8.0943 Cr 7.1727 Cr 0.0000 Cr -0.7774 Cr
2024-03-31 -10.7034 Cr -12.2147 Cr 23.1564 Cr -14.0056 Cr 0.2382 Cr 0.5408 Cr -3.3022 Cr 6.1651 Cr -1.5244 Cr 0.0000 Cr -4.3861 Cr
2023-03-31 4.6844 Cr -0.9911 Cr -3.7301 Cr 3.5882 Cr -0.0368 Cr 0.3025 Cr -1.0962 Cr 4.9444 Cr -3.4998 Cr 0.0000 Cr -3.6002 Cr
2022-03-31 8.5199 Cr -0.6733 Cr -7.6815 Cr 7.8364 Cr 0.1651 Cr 0.3393 Cr -0.6835 Cr 4.8786 Cr -9.1042 Cr 0.0000 Cr -0.8326 Cr
2021-03-31 0.5829 Cr -0.4176 Cr -0.2567 Cr 0.1487 Cr -0.0914 Cr 0.1742 Cr -0.4342 Cr 1.4121 Cr -2.8489 Cr 0.0000 Cr 0.7489 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 17.89 Cr 11.11 Cr 6.78 Cr 0.3788 2.48 Cr 1.73 Cr 1.46 2.68 Cr 0.0967
2025-03-31 18.18 Cr 11.68 Cr 6.50 Cr 0.3573 2.43 Cr 2.19 Cr 1.87 3.04 Cr 0.1202
2024-12-31 17.35 Cr 9.93 Cr 7.42 Cr 0.4277 2.39 Cr 1.90 Cr 1.62 2.86 Cr 0.1094
2024-09-30 18.13 Cr 12.66 Cr 5.47 Cr 0.3017 2.71 Cr 2.30 Cr 1.96 3.24 Cr 0.1266
2024-06-30 16.44 Cr 11.52 Cr 4.92 Cr 0.2992 2.20 Cr 1.71 Cr 1.47 2.42 Cr 0.1043

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 2.41 Cr 0.93 Cr 2.41 Cr 16.68 Cr 10.51 Cr 34.18 Cr 39.67 Cr 78.20 Cr 38.33 Cr
2024-09-30 0.26 Cr 4.93 Cr 5.20 Cr 9.90 Cr 2.63 Cr 30.31 Cr 17.58 Cr 50.22 Cr 18.31 Cr
2024-03-31 0.54 Cr 9.02 Cr 9.56 Cr 4.73 Cr 9.73 Cr 28.64 Cr 9.94 Cr 43.41 Cr 15.51 Cr
2023-09-30 0.22 Cr 1.75 Cr 1.97 Cr 7.22 Cr 4.45 Cr 13.65 Cr 9.78 Cr 24.33 Cr 24.14 Cr
2023-03-31 0.30 Cr 0.34 Cr 0.30 Cr 2.03 Cr 5.35 Cr 8.27 Cr 7.57 Cr 21.01 Cr 24.08 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 1.65 Cr 1.65 Cr 0.00 Cr 0.00 Cr 1.43 Cr 1.65 Cr 0.22 Cr 0.00 Cr 1.65 Cr
2023-09-30 1.71 Cr 1.71 Cr 0.00 Cr 0.00 Cr 1.71 Cr 0.22 Cr -1.49 Cr 0.00 Cr 1.71 Cr
2023-06-30 1.55 Cr 1.55 Cr 0.00 Cr 0.00 Cr 1.25 Cr 1.55 Cr 0.30 Cr 0.00 Cr 1.55 Cr
2023-03-31 1.00 Cr 1.00 Cr 0.00 Cr 0.00 Cr 1.00 Cr 0.30 Cr -0.69 Cr 0.00 Cr 1.00 Cr
2022-12-31 0.95 Cr 0.95 Cr 0.00 Cr 0.00 Cr 0.67 Cr 0.95 Cr 0.28 Cr 0.00 Cr 0.95 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹763.10 ₹91,376,415,181.00 ₹234,880.00

Key Executives

Executive Director
Mr. Srivardhan Ashwani Khemka

Gender: male

Year Born: 1996

Chief Financial Officer
Mr. Pritesh Jain

Gender: male

Year Born: 1982

Company Secretary & Compliance Officer
Mr. Ravikumar Venkatramalu Bogam

Gender: male

Year Born: 1987

Chairman & MD
Mr. Ashwani Anamisharan Khemka B.A

Gender: male

Year Born: 1971

FAQs about Sanjivani Paranteral Limited.

Who is the CEO of the company?

The CEO is Ashwani Anamisharan Khemka B.A.

What is the current market price of the stock?

The current price is ₹219.00.

What is the 52-week price range?

The range is ₹203.1-396.95.

What is the market capitalization of the company?

The market capitalization is ₹269.03 crores.

What is the dividend yield?

The dividend yield is 0.23%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 32.00.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Sanjivani Paranteral Limited. (ISIN: INE860D01013) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹269.03 crores and an average daily volume of 8,883 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.5.